BIP
FLNA

Brandes Investment Partners’s Filana Therapeutics FLNA Stock Holding History

Brandes Investment Partners’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-7,600
Closed -$53K – 191
2016
Q3 		$53K Sell
7,600
-3,651
-32% -$60.5K ﹤0.01% 180
2016
Q2 		$172K Buy
11,251
+5,863
+109% +$93K ﹤0.01% 155
2016
Q1 		$84K Buy
5,388
+2,796
+108% +$36.2K ﹤0.01% 163
2015
Q4 		$32K Sell
2,592
-113
-4% -$1.5K ﹤0.01% 172
2015
Q3 		$35K Buy
+2,705
New +$34.1K ﹤0.01% 168

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ZIM
Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return

Brandes Investment Partners's FLNA Position: Q4 2016 in Review

Brandes Investment Partners sold out of Filana Therapeutics (FLNA) in Q4 2016, closing a stake of 7,600 shares — an estimated $53K sold.

Brandes Investment Partners first reported a position in FLNA in Q3 2015 and held it in 5 quarters. The position peaked at $172K in Q2 2016. 46 funds tracked by Wall St. Rank hold FLNA as of Q4 2016.

  • Brandes Investment Partners reported no remaining Filana Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Brandes Investment Partners sold 7,600 Filana Therapeutics shares in Q4 2016, an estimated $53K.
  • Brandes Investment Partners first reported a position in Filana Therapeutics in Q3 2015 and held it in 5 quarters.
  • Brandes Investment Partners's Filana Therapeutics position peaked at $172K in Q2 2016.
  • 46 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2016.

Based on Brandes Investment Partners's 13F filing for Q4 2016, filed 10 Feb 2017.